CERS
Cerus Corporation
NASDAQ · Healthcare · Medical - Devices · US
$2.59
+0.78%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 102.60x
- P/S forward
- 1.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.45x
- Price / sales
- 2.36x
- Price / cash flow
- 215.95x
Enterprise value
- Enterprise value
- $543.2M
- EV / sales
- 2.45x
- EV / EBITDA
- 186.79x
- EV / EBIT
- -335.92x
- Market cap
- $521.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026